Prevention of adjuvant arthritis by the W3/25 anti-CD4 monoclonal antibody is associated with a decrease of blood CD4+CD45RChigh T cells

Clinical and Experimental Immunology

Volumn 125, Issue 3, 2001, Pages 470-477

  Pelegria C ^a   Castell, M ^a   Serra, M ^a   Rabanal, M ^a   Rodriaguez Palmero M ^a   Castellote, C ^a   Franch, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anti CD4 monoclonal antibody; Arthritis; CD45RC; Immunotherapy; Th1 Th2

Indexed keywords

CD45 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; OKT 4;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; LATENT PERIOD; LYMPH NODE; MYCOBACTERIUM; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD45; ARTHRITIS, EXPERIMENTAL; FEMALE; LYMPH NODES; MYCOBACTERIUM; RATS; RATS, WISTAR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 0035716194     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01592.x     Document Type: Article

References (39)

1. Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: Parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25
2. Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis
3. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
4. Induction of Th1 and Th2, CD4+ T cell responses: The alternative approaches
5. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs
6. Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response
7. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis
8. The leukocyte common antigen family
9. MRC OX-22, a new monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen
10. T-cell memory: The connection between function, phenotype and migration pathways
11. Rapid re-expression of CD45RC on rat CD4 T cells in vitro correlates with a change in function
12. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats
13. + intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization
14. Functional maturation of recent thymic emigrants in the periphery: Development of alloreactivity correlates with the cyclic expression of CD45RC isoforms
15. low subset
16. + T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion
17. - thymocytes
18. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into pre-diabetic recipients
19. + T cells
20. T-lymphocyte heterogeneity in the rat: Separation of functional subpopulations using a monoclonal antibody
21. Kinetics of W3/25 anti-rat CD4 monoclonal antibody. Studies on optimal doses and time-related effects
22. high T cells
23. MRC OX-19: A monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses
24. Two subsets of rat T lymphocytes defined with monoclonal antibodies
25. Time course of antibodies against IgG and type II collagen in adjuvant arthritis. Role of mycobacteria administration in antibody production
26. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis
27. Th1/Th2 cytokine balance in arthritis
28. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis
29. Cytokine gene activation in synovial membrane, regional lymph nodes, and spleen during the course of rat adjuvant arthritis
30. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease
31. + T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice
32. + cells in patients with rheumatoid arthritis
33. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage
34. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro
35. Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4
36. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines
37. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts
38. Interferon γ, IL-2, IL-10, TNFα secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody
39. Ability of a nondepleting anti-CD4 antibody to inhibit Th2 responses and allergic lung inflammation is independent of coreceptor function